⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONC News
BeOne Medicines Ltd. American Depositary Shares
L'FDA statunitense concede la revisione prioritaria a TEVIMBRA di BeOne Medicines nel trattamento di prima linea dell'adenocarcinoma gastroesofageo HER2 positivo
businesswire.com
ONC
L'FDA statunitense concede la revisione prioritaria a TEVIMBRA di BeOne Medicines nel trattamento di prima linea dell'adenocarcinoma gastroesofageo HER2 positivo
businesswire.com
ONC
La FDA de Estados Unidos otorga revisión prioritaria a TEVIMBRA de BeOne Medicines en primera línea para HER2+ GEA
businesswire.com
ONC
JAZZ
A FDA dos EUA concede revisão prioritária ao TEVIMBRA da BeOne Medicines para o tratamento de primeira linha do adenocarcinoma gastroesofágico HER2+
businesswire.com
ONC
美國FDA授予BeOne Medicines的TEVIMBRA用於HER2陽性胃食管腺癌一線治療的優先審評資格
businesswire.com
ONC
La FDA américaine accorde une évaluation prioritaire au TEVIMBRA de BeOne Medicines dans le traitement de première intention de l’adénocarcinome gastro-œsophagien HER2+
businesswire.com
ONC
Die US-amerikanische FDA bewilligt die vorrangige Prüfung von TEVIMBRA von BeOne Medicines als Erstlinienbehandlung bei HER2+ GEA
businesswire.com
ONC
Amerikaanse FDA kent Priority Review toe aan BeOne Medicines’ TEVIMBRA in eerstelijns HER2+ GEA
businesswire.com
ONC
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
businesswire.com
ONC
Form 8-K
sec.gov
BEIGF
ONC